Photo: Getty Images

A major rule change from the Food and Drug Administration (FDA) is expected to make abortion induced by medicine, rather than surgery, more common and easier to obtain for women in areas of the country without nearby clinics.

Under the new rule, women who are prescribed abortion medication will only have to visit the doctor twice, instead of three times. The agency also lowered the required dosage of mifepristone from 600 mg to 200 mg, a change that some say will make medical abortions more attractive because the smaller dosage will mean fewer painful side effects.

Complete your profile to continue reading and get FREE access to, part of your ALM digital membership.

Your access to unlimited content isn’t changing.
Once you are an ALM digital member, you’ll receive:

  • Critical information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and events.
  • Access to other award-winning ALM websites including and

Already have an account?

Jack Craver



Join BenefitsPRO

Don’t miss crucial news and insights you need to navigate the shifting employee benefits industry. Join now!

  • Unlimited access to - your roadmap to thriving in a disrupted environment
  • Access to other award-winning ALM websites including and
  • Exclusive discounts on and ALM events.

Already have an account? Sign In Now
Join BenefitsPRO

Copyright © 2023 ALM Global, LLC. All Rights Reserved.